665 3rd Street
TAXA Biotechnologies was founded in 2013 and has its principal office in San Francisco, California. TAXA Biotechnologies is a company of biologists and experts who use synthetic biology technologies to engineer new organisms which can be nurtured at home as carbon-positive alternatives to existing products. The first biotech investment by Y Combinator, TAXA Biotechnologies provides access to a platform for protein engineering, automated DNA assembly, transient experiments and stable transformation as a service that is already being used by three partners.
CEO: Antony Evans
Chief Scientific Officer: Jihyun Moon
$250,000+ Crowdfunding Round